PSA Changes as a Surrogate for OS in Men with mCRPC

PSA Changes as a Surrogate for OS in Men with mCRPC

Andrew Armstrong, MD summarizes a Journal of Clinical Oncology article, PSA Changes as Surrogate for Overall Survival in Men with mCRPC Treated with Second-line Chemotherapy, from November 2013.

Andrew J. Armstrong, MD
Duke University School of Medicine

Click HERE to read the abstract